Barely Significant
← all excerpts

KIBRA; a novel biomarker predicting recurrence free survival of breast cancer patients receiving adjuvant therapy.

BMC Cancer · 2018 · PMC5968668 · PMID 29793439

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

did not reach statistical significancep = 0.05actually significant
3b ) However, the difference between the survival curves of the four types did not reach statistical significance ( p = 0.05).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.